Farms.com Home   News

European Scientists Highlight Worrisome H5N1 Avian Flu Mutations

By Lisa Schnirring

In an updated assessment on H5N1 avian influenza, European health groups said though the risk to humans is still low, worrisome signs include the appearance of certain mutations in circulating strains and mass animal mortality events that hint at a greater risk of spread among mammals.

mammles

The assessment comes from the European Food Safety Agency, the European Centre for Disease Prevention and Control (ECDC), and the European Union reference lab and was posted today on the ECDC's website. It covers data collected from December 2022 to March 1.

Gull patterns increase threat to poultry

Officials said poultry outbreaks have declined in the region since a peak in November, but, given mass die-offs in gulls in multiple countries due to the virus, poultry outbreaks involving the 2.3.4.4b H5N1 clade could increase in the months ahead.

Gulls will be moving inland to breeding colonies that overlap poultry-production areas, the report notes. The 2.3.4.4b H5N1 clade is now circulating on multiple continents.

In the full 43-page report, the groups said that, from September to March, virus detections in seabirds were unexpectedly high, especially in gulls, with large morality events seen in France, Belgium, the Netherlands, and Italy. Genetic analysis of viruses from black-headed gulls points to a southward spread of the virus and that it persisted after the summer in resident wild birds.

More genetic changes following mammal infections

Genetic analysis of the viruses from infected European birds over the winter suggests that H5N1 still binds preferentially to avian receptors.

The experts note, however, that some of the viruses from mammals have markers in the PB2 protein associated with increased virulence and replication in mammals—very rarely seen before 2020. They said the changes probably emerged following transmission to animals and possibly have public health implications.

The groups said most recent H5N1 detections in mammals involve species such as red fox that hunt or scavenge infected birds or dead animals. However, they pointed to three mass mortality events: one involving harbor seals in Maine, an outbreak at a Spanish mink farm, and a die-off in Peruvian sea lions.

Transmission events to and between mammals, serologic evidence of infection in wild boar and pigs, and mutations that would make the virus better adapted to mammals are concerning and need to be closely followed, they said.

More sporadic infections in humans are possible in people exposed to sick or dead birds, and the groups put that risk as moderate. The recent severe cases from Asia and South America underscore the risk of unprotected contact with infected birds, they note. The risk of travel-related cases in humans is very low.

Source : umn.edu

Trending Video

New Solution Powers Efficient Pork Growth

Video: New Solution Powers Efficient Pork Growth


Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.